Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia

scientific article published on 21 February 2012

Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2012PNAS..109.3927M
P356DOI10.1073/PNAS.1119858109
P932PMC publication ID3309760
P698PubMed publication ID22355108
P5875ResearchGate publication ID221851914

P50authorAlan E MastQ90260520
P2093author name stringPeter B Johansen
Lars C Petersen
Susan A Maroney
Mette B Hermit
Catherine E Bonesho
Josephine P Ferrel
Brian C Cooley
Lone V Nielsen
P2860cites workStructure and biology of tissue factor pathway inhibitorQ28202845
Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasmaQ28254514
In vivo fluorescence imaging of large-vessel thrombosis in miceQ30500329
Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactorQ33822980
Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficitQ33843110
Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesisQ33895278
AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER.Q34257237
WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.Q34257361
Active tissue factor pathway inhibitor is expressed on the surface of coated plateletsQ35642785
The role of tissue factor pathway inhibitor in a revised coagulation cascadeQ36370143
Combined tissue factor pathway inhibitor and thrombomodulin deficiency produces an augmented hypercoagulable state with tissue-specific fibrin depositionQ36823197
Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice.Q37418452
Alternatively spliced isoforms of tissue factor pathway inhibitorQ37696775
Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A.Q40575096
Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growthQ42700253
Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases.Q42950062
Targeted disruption of the mouse factor VIII gene produces a model of haemophilia AQ45868121
Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitorQ45868138
Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.Q45871920
Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A.Q45872405
Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A.Q45876184
Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmasQ45881092
Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.Q52526571
Thrombin Induces the Redistribution and Acute Release of Tissue Factor Pathway Inhibitor From Specific Granules Within Human Endothelial Cells in CultureQ53722832
Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1Q57374924
Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasmaQ67866847
Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitorQ70412786
Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboonsQ73307852
Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitorQ74192371
Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factorsQ77677300
Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V LeidenQ78057268
A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult miceQ81144269
P4510describes a project that usesImageJQ1659584
P433issue10
P407language of work or nameEnglishQ1860
P921main subjecthemophiliaQ134003
P304page(s)3927-3931
P577publication date2012-02-21
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titleAbsence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia
P478volume109

Reverse relations

cites work (P2860)
Q92020423A Molecular Revolution in the Treatment of Hemophilia
Q35784515A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic development
Q35126274Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor
Q57289034Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia
Q64113389Assessing Blood Clotting and Coagulation Factors in Mice
Q33585249Biology of tissue factor pathway inhibitor.
Q34657739Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets
Q37268966Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor
Q36852177Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβ
Q55447752Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S.
Q92218948Defective fibrin deposition and thrombus stability in Bambi-/- mice are mediated by elevated anticoagulant function
Q39952594Development of a tail vein transection bleeding model in fully anaesthetized haemophilia A mice - characterization of two novel FVIII molecules.
Q55123953Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia.
Q45863501Engineering a new generation of hemostatic agents: highlights of the Scientific Session on Hemostasis at the 2013 meeting of the American Society of Hematology
Q38114123Hemophilia A and hemophilia B: focus on arthropathy and variables affecting bleeding severity and prophylaxis
Q55346403Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab.
Q61796552Maintaining extraembryonic expression allows generation of mice with severe tissue factor pathway inhibitor deficiency
Q90683939Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophilia
Q26865048New insights into the biology of tissue factor pathway inhibitor
Q38604626New products for the treatment of haemophilia
Q38293116Novel therapeutic approaches for haemophilia
Q36269547Platelet full length TFPI-α in healthy volunteers is not affected by sex or hormonal use.
Q36169665Platelet-Derived Short-Chain Polyphosphates Enhance the Inactivation of Tissue Factor Pathway Inhibitor by Activated Coagulation Factor XI.
Q37007335Platelets: Context-Dependent Vascular Protectors or Mediators of Disease
Q33648222Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor
Q47900623Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex
Q93192263Serum lipoprotein(a) and risk of hemorrhagic stroke among incident peritoneal dialysis patients: a large study from a single center in China
Q93206771Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A
Q37108074Targeting TFPI for hemophilia treatment
Q47215919Targeting anticoagulant protein S to improve hemostasis in hemophilia.
Q55211396The Potential Close Future of Hemophilia Treatment - Gene Therapy, TFPI Inhibition, Antithrombin Silencing, and Mimicking Factor VIII with an Engineered Antibody.
Q38840382The hemostatic role of factor XI.
Q36403196Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein
Q37276726Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation
Q33706688Translation of human tissue factor pathway inhibitor-β mRNA is controlled by alternative splicing within the 5' untranslated region.

Search more.